Cited by 2,337Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancerCancer-related Molecular Pathways

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, Stephan A., Schutte, Mieke, Shamsul Hoque, A. T. M., Moskaluk, Christopher A., da Costa, Luis T., Rozenblum, Ester, Weinstein, Craig L., Fischer, Aryeh, Yeo, Charles J., Hruban, Ralph H., Kern, Scott E.·1996·Science

DOI 10.1126/science.271.5247.350

Open this paper in CoChat — free account

Abstract

About 90 percent of human pancreatic carcinomas show allelic loss at chromosome 18q. To identify candidate tumor suppressor genes on 18q, a panel of pancreatic carcinomas were analyzed for convergent sites of homozygous deletion. Twenty-five of 84 tumors had homozygous deletions at 18q21.1, a site that excludes DCC (a candidate suppressor gene for colorectal cancer) and includes DPC4 , a gene similar in sequence to a Drosophila melanogaster gene ( Mad ) implicated in a transforming growth factor-β (TGF-β)-like signaling pathway. Potentially inactivating mutations in DPC4 were identified in six of 27 pancreatic carcinomas that did not have homozygous deletions at 18q21.1. These results identify DPC4 as a candidate tumor suppressor gene whose inactivation may play a role in pancreatic and possibly other human cancers.

Integrity signals

Registry

Crossref · 10.1126/science.271.5247.350

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D. K., Forrester, K., Wj, M., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,122
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Tumor Suppressor Genes
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,765
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,760
Self-citation
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,674
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Thermal asymmetric interlaced PCR: automatable amplification and sequencing of insert end fragments from P1 and YAC clones for chromosome walking
Liu, Y., & Whittier, R. F. (1995) · Genomics · doi:10.1016/0888-7543(95)80010-j · Cited by 1,141
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132
Self-citation

Flagged first, then by citations

Show all 25 references

Research works printed but not linked: 2

HAHN A. S., IN PRESS CANCER RES .
LEACH S. F., COMMUNICATION .

Sorted by citations

Items 101–200 of 1,002

TGF-β signaling by Smad proteins
Miyazono, K., ten Dijke, P., & Heldin, C. (2000) · Advances in immunology · doi:10.1016/s0065-2776(00)75003-6 · Cited by 440
TGF-β signalling and its role in cancer progression and metastasis
Drabsch, Y., & ten Dijke, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9375-7 · Cited by 430
Pancreatic cancer biology and genetics from an evolutionary perspective
Makohon-Moore, A. P., & Iacobuzio–Donahue, C. A. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.66 · Cited by 436
Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray
Maitra, A., Adsay, N. V., Argani, P., Iacobuzio-Donahue, C., De Marzo, A., Cameron, J. L., Yeo, C. J., & Hruban, R. H. (2003) · Modern Pathology · doi:10.1097/01.mp.0000086072.56290.fb · Cited by 429
Self-citation
p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.
Moskaluk, C. A., Hruban, R. H., & Kern, S. E. (1997) · PubMed · Cited by 429
Self-citation
Role of Ras and Mapks in TGFβ signaling
Mulder, K. M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00026-x · Cited by 348
Xenopus Mad Proteins Transduce Distinct Subsets of Signals for the TGFβ Superfamily
Graff, J. M., Bansal, A., & Melton, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81249-0 · Cited by 424
Biology and management of pancreatic cancer
Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2007) · Postgraduate Medical Journal · doi:10.1136/gut.2006.103333 · Cited by 419
Nucleocytoplasmic Shuttling of Smads 2, 3, and 4 Permits Sensing of TGF-β Receptor Activity
Inman, G. J., Nicolás, F. J., & Hill, C. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00585-3 · Cited by 417
Germline and Somatic Mutations of the STK11/LKB1 Peutz-Jeghers Gene in Pancreatic and Biliary Cancers
Su, G. H., Hruban, R. H., Bansal, R. K., Bova, G. S., Tang, D. J., Shekher, M. C., Westerman, A. M., Entius, M. M., Goggins, M., Yeo, C. J., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65440-5 · Cited by 417
Self-citation
Tumor suppressor activity of the TGF-β pathway in human cancers
Markowitz, S. D. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00001-9 · Cited by 416
Targeting TGFβ signal transduction for cancer therapy
Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413
“For example, TβRII mutations are frequently found in colorectal cancer (CRC),90 SMAD2 mutations have been reported in CRC, hepatocellular carcinoma (HCC), and lung cancer,91,92 and the deletion or mutation of SMAD4 is often identified in pancreatic cancer, CRC, and HCC.93,94 There are several advanced tumors that stil…”
Background
Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3
Chen, S.-J., Yuan, W., Mori, Y., Levenson, A. S., Varga, J., & Trojanowska, M. E. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00477.x · Cited by 411
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Haeno, H., Gönen, M., Davis, M. B., Herman, J. M., Iacobuzio–Donahue, C. A., & Michor, F. (2012) · Cell · doi:10.1016/j.cell.2011.11.060 · Cited by 412
Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression
Weber, R. G., Boström, J. P., Wolter, M., Baudis, M., Collins, V. P., Reifenberger, G., & Lichter, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14719 · Cited by 405
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF‐β
Feng, X., Lin, X., & Derynck, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5178 · Cited by 404
DNA Copy Number Losses in Human Neoplasms
Knuutila, S., Aalto, Y., Autio, K., Björkqvist, A., El-Rifai, W. M., Hemmer, S., Huhta, T., Kettunen, E., Kiuru‐Kuhlefelt, S., Larramendy, M. L., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65166-8 · Cited by 391
The dynamic roles of TGF‐β in cancer
Meulmeester, E., & ten Dijke, P. (2010) · The Journal of Pathology · doi:10.1002/path.2785 · Cited by 399
Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling
Souchelnytskyi, S., Tamaki, K., Engström, U., Wernstedt, C., ten Dijke, P., & Heldin, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28107 · Cited by 382
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression
Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Fujitani, Y., Fujitani, S., Wright, C. V. E., & Moses, H. L. (2006) · Genes & Development · doi:10.1101/gad.1475506 · Cited by 379
Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15
lavarone, A., & Massagué, J. (1997) · Nature · doi:10.1038/387417a0 · Cited by 375
Genetic progression in the pancreatic ducts
Hruban, R. H., Wilentz, R. E., & Kern, S. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65054-7 · Cited by 373
Self-citation
Bone Morphogenetic Proteins: From Basic Studies to Clinical Approaches
Sakou, T. (1998) · Bone · doi:10.1016/s8756-3282(98)00053-2 · Cited by 367
BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.
Wong, A. K., Shanahan, F., Chen, Y., Lian, L., Ha, P. C., Hendricks, K., Ghaffari, S. R., Iliev, D., Penn, B., Woodland, A.-M., et al. (2000) · PubMed · Cited by 364
The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice
Yang, X. Y., Li, C., Xu, X., & Deng, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3667 · Cited by 362
Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder, V., Hendler, S. F., Boeck, W., Seufferlein, T., Menke, A., Ruhland, C., Adler, G., & Gress, T. M. (2001) · PubMed · Cited by 361
Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4
Hata, A., Lo, R. S., Wotton, D., Lagna, G., & Massagué, J. (1997) · Nature · doi:10.1038/40424 · Cited by 361
Determinants of specificity in TGF-β signal transductionPreprint
Chen, Y., Hata, A., Lo, R. S., Wotton, D., Shi, Y., Pavletich, N. P., & Massagué, J. (1998) · Genes & Development · doi:10.1101/gad.12.14.2144 · Cited by 361
Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells
Liu, X., Sun, Y., Constantinescu, S. N., Karam, E., Weinberg, R. A., & Lodish, H. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10669 · Cited by 356
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J. J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 367
Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard, L., Zöchbauer‐Müller, S., Virmani, A. K., Gazdar, A. F., & Minna, J. D. (2000) · PubMed · Cited by 344
Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?
Micke, P., & tman, A. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.07.977 · Cited by 346
Smad4 Dependency Defines Two Classes of Transforming Growth Factor β (TGF-β) Target Genes and Distinguishes TGF-β-Induced Epithelial-Mesenchymal Transition from Its Antiproliferative and Migratory Responses
Lévy, L., & Hill, C. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8108-8125.2005 · Cited by 354
The Concise Handbook of Family Cancer Syndromes
Lindor, N. M., Greene, M. H., & Program, M. F. C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.14.1039 · Cited by 338
Positive and negative regulation of TGF-β signaling
Miyazono, K. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.7.1101 · Cited by 347
Pancreatic cancer: why is it so hard to treat?
Oberstein, P. E., & Olive, K. P. (2013) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x13478680 · Cited by 334
A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway.Preprint
Baker, J. C., & Harland, R. M. (1996) · Genes & Development · doi:10.1101/gad.10.15.1880 · Cited by 340
Inflammation and the development of pancreatic cancer
Farrow, B., & Evers, B. M. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00015-4 · Cited by 338
Making sense of cancer genomic dataPreprint
Chin, L., Hahn, W. C., Getz, G. A., & Meyerson, M. M. (2011) · Genes & Development · doi:10.1101/gad.2017311 · Cited by 344
Role of Smads in TGFβ signaling
Heldin, C., & Moustakas, A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1190-x · Cited by 335
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
Wang, L., Wu, C., Rajasekaran, N., & Shin, Y. K. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495956 · Cited by 360
Deletions of the Short Arm of Chromosome 3 in Solid Tumors and the Search for Suppressor Genes
Kok, K., Naylor, S. L., & Buys, C. H. C. M. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60096-2 · Cited by 334
Cellular and molecular mechanisms of action of bisphosphonates
Rogers, M. J., Gordon, S., Benford, H. L., Coxon, F. P., Luckman, S. P., Mönkkönen, J., & Frith, J. C. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+ · Cited by 982
Genetic profile of 22 pancreatic carcinoma cell lines: Analysis of K-ras, p53, p16 and DPC4/Smad4
Moore, P. S., Sipos, B., Orlandini, S., Sorio, C., Real, F. X., Lemoine, N. R., Gress, T., Bassi, C., Klöppel, G., Kalthoff, H., et al. (2001) · Virchows Archiv · doi:10.1007/s004280100474 · Cited by 329
LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Melisi, D., Ishiyama, S., Sclabas, G. M., Fleming, J. B., Xia, Q., Tortora, G., Abbruzzese, J. L., & Chiao, P. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0337 · Cited by 324
Smad4 signalling in T cells is required for suppression of gastrointestinal cancer
Kim, B., Li, C., Qiao, W., Mamura, M., Kasperczak, B., Anver, M. R., Wolfraim, L. A., Hong, S., Mushinski, E. B., Potter, M., et al. (2006) · Nature · doi:10.1038/nature04846 · Cited by 325
TGF-β Family Signal Transduction in Drosophila Development: From Mad to Smads
Raftery, L. A., & Sutherland, D. J. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9282 · Cited by 322
Defective repression of c- myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program
Chen, C.-R., Kang, Y., & Massagué, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.992 · Cited by 321
Pancreatic cancer
Yeo, T. P., Hruban, R. H., Leach, S. D., Wilentz, R. E., Sohn, T. A., Kern, S. E., Iacobuzio–Donahue, C. A., Maitra, A., Goggins, M., Canto, M. I., et al. (2002) · Current Problems in Cancer · doi:10.1067/mcn.2002.129579 · Cited by 321
Self-citation
Regulation and function of somatostatin receptors
Olias, G., Viollet, C., Kusserow, H., Epelbaum, J., & Meyerhof, W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02402.x · Cited by 322
Stromal biology of pancreatic cancer
Chu, G. C., Kimmelman, A. C., Hezel, A. F., & DePinho, R. A. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21209 · Cited by 330
Smad5 and DPC4 Are Key Molecules in Mediating BMP-2-induced Osteoblastic Differentiation of the Pluripotent Mesenchymal Precursor Cell Line C2C12
Nishimura, R., Kato, Y., Chen, D., Harris, S. E., Mundy, G. R., & Yoneda, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1872 · Cited by 319
Vascular MAD s: Two novel MAD -related genes selectively inducible by flow in human vascular endothelium
Topper, J. N., Cai, J., Qiu, Y., Anderson, K. R., Xu, Y., Deeds, J. D., Feeley, R., Gimeno, C. J., Woolf, E. A., Tayber, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9314 · Cited by 319
GENETIC AND EPIGENETIC ALTERATIONS IN COLON CANCER
Grady, W. M., & Markowitz, S. D. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103043 · Cited by 323
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
Initiative, A. P. C. G., Pérez-Mancera, P. A., Rust, A. G., van der Weyden, L., Kristiansen, G., Li, A., Sarver, A. L., Silverstein, K. A. T., Grützmann, R., Aust, D., et al. (2012) · Nature · doi:10.1038/nature11114 · Cited by 316
Self-citation
Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency
Tang, B., Böttinger, E. P., Jakowlew, S. B., Bagnall, K. M., Mariano, J. M., Anver, M. R., Letterio, J. J., & Wakefield, L. M. (1998) · Nature Medicine · doi:10.1038/nm0798-802 · Cited by 315
TGF-β signal transduction and mesangial cell fibrogenesis
Schnaper, H. W., Hayashida, T., Hubchak, S. C., & Poncelet, A.-C. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00300.2002 · Cited by 312
The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function
Zhang, Y. E., Musci, T. J., & Derynck, R. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00123-0 · Cited by 310
Untitled work
(2001) · PubMed · Cited by 309
Self-citation
Progression of Pancreatic Intraductal Neoplasias to Infiltrating Adenocarcinoma of the Pancreas
Brat, D. J., Lillemoe, K. D., Yeo, C. J., Warfield, P. B., & Hruban, R. H. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199802000-00003 · Cited by 309
Self-citation
A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform
Sipos, B., Möser, S., Kalthoff, H., Török, V., Löhr, M. J., & Klöppel, G. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0784-4 · Cited by 309
Mad-related genes in the human
Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1996) · Nature Genetics · doi:10.1038/ng0796-347 · Cited by 308
Self-citation
Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers
Leary, R. J., Lin, J., Cummins, J. M., Boca, S. M., Wood, L. D., Parsons, D. W., Jones, S., Sjöblom, T., Park, B.-H., Parsons, R. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808041105 · Cited by 305
The DCC Protein and Prognosis in Colorectal Cancer
Shibata, D., Reale, M. A., Lavin, P. T., Silverman, M. L., Fearon, E. R., Steele, G. D., Jessup, J. M., Loda, M. F., & Summerhayes, I. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612053352303 · Cited by 307
Hedgehog/Ras interactions regulate early stages of pancreatic cancerPreprint
di Magliano, M. P., Sekine, S., Ermilov, A. N., Ferris, J., Dlugosz, A. A., & Hebrok, M. (2006) · Genes & Development · doi:10.1101/gad.1470806 · Cited by 302
Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas
Wilentz, R. E., Su, G. H., Dai, J. L., Sparks, A. B., Argani, P., Sohn, T. A., Yeo, C. J., Kern, S. E., & Hruban, R. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64703-7 · Cited by 304
Self-citation
The Transforming Growth Factor‐βs
Bottner, M. B., KRIEGLSTEIN, K. G., & Unsicker, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752227.x · Cited by 302
Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens
Reddi, A. H. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00049-4 · Cited by 301
Crystal Structure of a Phosphorylated Smad2
Wu, J.-W., Hu, M., Chai, J., Seoane, J., Huse, M., Li, C., Rigotti, D. J., Kyin, S., Muir, T. W., Fairman, R., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00421-x · Cited by 300
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Chen, X., Chu, Q., Shi, Q., Zeng, Y., Lu, J., & Li, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02142-w · Cited by 347
Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2
Weinstein, M. B., Yang, X. Y., Li, C., Xu, X., Gotay, J., & Deng, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9378 · Cited by 300
Two distinctp53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis
Ren, Z.-P., Pontén, F., Nistér, M., & Pontén, I. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960621)69:3 · Cited by 98
Clinicopathological Correlates of Pancreatic Intraepithelial Neoplasia: A Comparative Analysis of 82 Cases With and 152 Cases Without Pancreatic Ductal Adenocarcinoma
Andea, A. A., Sarkar, F. H., & Adsay, V. N. (2003) · Modern Pathology · doi:10.1097/01.mp.0000087422.24733.62 · Cited by 290
TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers
Freudlsperger, C., Bian, Y., Wise, S. C., Burnett, J., Coupar, J. F., Yang, X., Chen, Z., & Waes, C. V. (2012) · Oncogene · doi:10.1038/onc.2012.171 · Cited by 290
Control of the cell cycle and apoptosis
Weinberg, R. A., & Lundberg, A. S. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00046-5 · Cited by 288
Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors
Kawabata, M., Inoue, H., Hanyu, A., Imamura, T., & Miyazono, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.4056 · Cited by 289
The hedgehog pathway and basal cell carcinomas
Bale, A. E. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.757 · Cited by 288
Frequency of Smad gene mutations in human cancers.
Riggins, G. J., Kinzler, K. W., Vogelstein, B., & Thiagalingam, S. (1997) · PubMed · Cited by 285
Annotating Cancer Variants and Anti-Cancer Therapeutics in Reactome
Orlic-Milacic, M., Haw, R., Rothfels, K., Wu, G., Croft, D. W., Hermjakob, H., D’Eustachio, P., & Stein, L. D. (2012) · Cancers · doi:10.3390/cancers4041180 · Cited by 281
Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways
Käkönen, S.-M., Selander, K. S., Chirgwin, J. M., Yin, J. J., Burns, S. S., Rankin, W. A., Grubbs, B. G., Dallas, M., Cui, Y., & Guise, T. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202561200 · Cited by 277
Transforming growth factor-β: a therapeutic target for cancer
Haque, S., & Morris, J. C. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1327107 · Cited by 276
Genetic and Immunohistochemical Analysis of Pancreatic Acinar Cell Carcinoma
Abraham, S. C., Wu, T., Hruban, R. H., Lee, J.-H., Yeo, C. J., Conlon, K. C., Brennan, M. F., Cameron, J. L., & Klimstra, D. S. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64917-6 · Cited by 275
Self-citation
Transforming Growth Factor β-Independent Shuttling of Smad4 between the Cytoplasm and Nucleus
Pierreux, C. E., Nicolás, F. J., & Hill, C. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.9041-9054.2000 · Cited by 274
Distinctive Molecular Genetic Alterations in Sporadic and Familial Adenomatous Polyposis-Associated Pancreatoblastomas
Abraham, S. C., Wu, T., Klimstra, D. S., Finn, L. S., Lee, J.-H., Yeo, C. J., Cameron, J. L., & Hruban, R. H. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63008-8 · Cited by 270
Self-citation
Tumor Suppressor Smad4 Is a Transforming Growth Factor β-Inducible DNA Binding Protein
Yingling, J. M., Datto, M., Wong, C., Frederick, J. P., Liberati, N. T., & Wang, X. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7019 · Cited by 272
Molecular genetics of pancreatic intraepithelial neoplasia
Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269
Self-citation
The Pathology and Genetics of Metastatic Pancreatic Cancer
Yachida, S., & Iacobuzio–Donahue, C. A. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.3.413 · Cited by 269
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations
Howe, J. R., Sayed, M. G., Ahmed, A. F., Ringold, J., Larsen-Haidle, J., Merg, A., Mitros, F. A., Vaccaro, C. A., Petersen, G. M., Giardiello, F. M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018598 · Cited by 267
The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF‐β receptors
Lo, R. S., Chen, Y., Shi, Y., Pavletich, N. P., & Massagué, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.996 · Cited by 266
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
Schwarte‐Waldhoff, I., Volpert, O. V., Bouck, N., Sipos, B., Hahn, S. A., Klein‐Scory, S., Lüttges, J., Klöppel, G., Graeven, U., Eilert-Micus, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9624 · Cited by 266
Self-citation
Colorectal cancer: genetics of development and metastasis
Takayama, T., Miyanishi, K., Hayashi, T., Sato, Y., & Niitsu, Y. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1801-6 · Cited by 275
Netrin-1 and its receptors in tumorigenesis
Arakawa, H. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1504 · Cited by 261
TGF-β signaling alterations and susceptibility to colorectal cancer
Xu, Y., & Pasche, B. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl486 · Cited by 271
TGF-β signalling through the Smad pathway
Massaous, J., & Hata, A. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01036-2 · Cited by 265
Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-β Signaling
Sun, Y., Liu, X., Eaton, E. N., Lane, W. S., Lodish, H. F., & Weinberg, R. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80201-4 · Cited by 263
Molecular prognostic markers in pancreatic cancer: A systematic review
Garcea, G., Neal, C. P., Pattenden, C. J., Steward, W. P., & Berry, D. P. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.044 · Cited by 257
The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer
Kleeff, J. H., Ishiwata, T., Maruyama, H., Frieß, H., Truong, P., Büchler, M. W., Falb, D., & Korc, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202909 · Cited by 258
Dpc-4 Protein Is Expressed in Virtually All Human Intraductal Papillary Mucinous Neoplasms of the Pancreas
Iacobuzio–Donahue, C. A., Klimstra, D. S., Adsay, V. N., Wilentz, R. E., Argani, P., Sohn, T. A., Yeo, C. J., Cameron, J. L., Kern, S. E., & Hruban, R. H. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64589-0 · Cited by 256
Self-citation
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus
Smeets, S. J., Braakhuis, B. J. M., Abbas, S., Snijders, P. J. F., Ylstra, B., van de Wiel, M. A., Meijer, G. A., Leemans, C. R., & Brakenhoff, R. H. (2005) · Oncogene · doi:10.1038/sj.onc.1209275 · Cited by 255
t(11;18)(q21;q21) is the most common translocation in MALT lymphomas
Auer, I. A., Gascoyne, R. D., Conners, J. M., Cotter, F. E., Greiner, T. C., Sanger, W. G., & Horsman, D. E. (1997) · Annals of Oncology · doi:10.1023/a:1008202303666 · Cited by 255

Authors: Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., & Kern, S. E.
Affiliations: Johns Hopkins University (US)
S. A. Hahn, M. Schutte, A. T. M. S. Hoque, C. A. Moskaluk, E. Rozenblum, C. L. Weinstein, A. Fischer, R. H. Hruban, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
L. T. da Costa, Graduate Program in Human Genetics and Molecular Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Corresponding author: Kern, Scott E.
ORCID: Hahn, Stephan A.
Moskaluk, Christopher A.
Fischer, Aryeh
Yeo, Charles J.
Hruban, Ralph H.
Kern, Scott E.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1996-01-19
Volume: 271
Issue: 5247
Pages: 350-353
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.271.5247.350
OpenAlex: W2100522747
Cited by: 2,337
References: 25
Citations by year: 2026: 20 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 31 · 2021: 41 · 2020: 33 · 2019: 44 · 2018: 41 · 2017: 46 · 2016: 55 · 2015: 59 · 2014: 71 · 2013: 64 · 2012: 67
FWCI: 70.80
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P50CA062924, CA 62924)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: SMAD4, tumor suppressor, pancreatic cancer, homozygous deletion, loss of heterozygosity, TGF-beta signaling, loss-of-function mutations, candidate gene identification
MeSH terms: Alleles, Amino Acid Sequence, Animals, Base Sequence, Cell Division, Chromosome Mapping, Chromosomes, Human, Pair 18, DNA-Binding Proteins, Genetic Markers, Humans, Molecular Sequence Data, Mutation, Neoplasm Transplantation, Pancreatic Neoplasms, Proteins, Transplantation, Heterologous, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Gene Expression, Genes, Tumor Suppressor, Transforming Growth Factor beta, Gene Deletion, Mice, Smad4 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks